Keryx Biopharmaceuticals, Inc.

(NASDAQ:KERX)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 19,065 19,065 19,065 48,736
Cash At End Of Period 6,779 14,037 5,774 19,065
Net Change In Cash And Cash Equivalents -12,286 -5,028 -13,291 -29,671
Effect Of Exchange Rate Changes — — — —
Net Income Or Loss -49,074 -42,233 -34,536 -90,062
Cash From Operating Activities
Depreciation Expenses 85 69 35 151
Amortization Expenses — — — —
Amortization Of Intangibles Expenses — — — —
Deferred Income Taxes — — — —
Operating Gains Or Losses — — — -1
Extraordinary Gains Or Losses — — — —
Increase Or Decrease In Receivables 61 184 -8,180 242
Increase Or Decrease In Inventories — — — —
Increase Or Decrease In Prepaid Expenses — — — —
Increase Or Decrease In Other Current Assets — — — —
Increase Or Decrease In Payables 573 129 14 718
Increase Or Decrease In Other Current Liabilities -12,666 -9,130 -2,347 8,674
Increase Or Decrease In Other Working Capital -236 -148 -140 -280
Other Non Cash Items 7,248 7,366 8,019 11,753
Net Cash From Continuing Operations 18,575 15,667 13,585 11,260
Net Cash From Discontinued Operations -35,434 -28,096 -23,550 -57,545
Net Cash From Operating Activities 43 — — —
Cash From Investing Activities
Sale Of Property Plant And Equipment — — — 15
Sale Of Long Term Investments — — — 3
Sale Of Short Term Investments — — — —
Purchase Of Property Plant And Equipment -146 -163 -163 -3,159
Acquisitions — — — —
Purchase Of Long Term Investments -1 -1 -1 -6,372
Purchase Of Short Term Investments -12,033 -12,032 -12,021 -62,836
Other Investing Changes Net — — — —
Cash From Discontinued Investing Activities — — — —
Net Cash From Investing Activities 22,883 22,846 10,037 27,871
Cash From Financing Activities
Issuance Of Debt 222 222 222 271
Issuance Of Capital Stock — — — —
Repayment Of Debt — — — -268
Repurchase Of Capital Stock — — — —
Payment Of Cash Dividends — — — —
Net Other Financing Charges — — — —
Cash From Discontinued Financing Activities — — — —
Net Cash From Financing Activities 222 222 222 3